Nebraska Hematology-Oncology
In research, Nebraska Hematology-Oncology stands highest in Medicine (#6,252 of 14,558 worldwide) and Health Sciences (#7,708 of 16,688 worldwide), over all time.
- World rank, all time
- #24,348 of 34,923
- Rank in United States
- #5,063 of 7,310
- Research works
- 253 ▼ 39% vs 2018-21
- Citations
- 8.6k 33.9 per fractional work
- Top-10% rate
- 14.8% all institutions 10.0%
- vs its own fields
- 1.07× 1.00× is exactly expected
- Open access
- 16% world 40%
- International
- 12% world 18%
What is Nebraska Hematology-Oncology known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #6,252 of 14,558 | 12.4% | 167 | |
| Health SciencesDomain | #7,708 of 16,688 | 12.4% | 182 |
Each strip is that field's whole ranked pool, with the notch where Nebraska Hematology-Oncology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Nebraska Hematology-Oncology work in?
In all years, 72% of research at Nebraska Hematology-Oncology is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (9%), Health Professions (3%). It does 3.0× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences18271.9%
- Medicine16765.9%
- Health Professions93.5%
- Nursing20.9%
- Veterinary20.9%
- Dentistry20.7%
- Life Sciences4316.8%
- Physical Sciences176.8%
- Engineering72.9%
- Environmental Science41.7%
- Chemistry20.9%
- Materials Science10.4%
- Physics and Astronomy10.4%
- Computer Science10.3%
- Mathematics00.1%
- Earth and Planetary Sciences00.0%
- Energy00.0%
- Chemical Engineering00.0%
- Social Sciences114.4%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 31.2×. Every wedge is a field page.
All 7 fields, with their numbers
- Veterinary31.20×0 works
- Medicine3.89×3 works
- Dentistry2.91×0 works
- Biochemistry, Genetics and Molecular Biology1.86×0 works
- Engineering0.57×0 works
- Health Professions0.27×0 works
- Computer Science0.07×0 works
Who are the top researchers at Nebraska Hematology-Oncology?
Ranked on the quality score, Eric Joseph Avery lead among researchers whose main affiliation is Nebraska Hematology-Oncology.
- 1
Eric Joseph Avery
United States · #1,747,310 worldwide 787 citations · 19 works
Which keywords describe research at Nebraska Hematology-Oncology?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Inflammation, Epidemiology, Immunotherapy, Guidelines, Neoadjuvant Therapy, Molecular Characterization and Diagnosis.
- Immunosuppressive Drugs
- Transplantation
- Rituximab
- Tumor Microenvironment
- Mesenchymal Stem Cells
- Cardiovascular Risk
- Complications
- Clinical Practice Guidelines
- Graft Survival
- Surgical Management
- Global Burden
- Bladder Cancer
- Cardiovascular Disease
- Risk Factors
- Molecular Characterization
- Neoadjuvant Therapy
- Diagnosis
- Guidelines
- Immunotherapy
- Inflammation
- Epidemiology
- Chemotherapy
- Oxidative Stress
- Treatment
- Cancer
- Quality of Life
- Prognostic Factors
- Management
- Urothelial Carcinoma
- Cystectomy
- Heart Failure
- Magnetic Resonance Imaging
- Genetic Mutations
- Mortality
- Autoantibodies
- Immunosuppressive Therapy
- Hematopoietic Stem Cells
- Clinical Outcomes
- Targeted Therapy
- Liver Transplantation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology21▲ 2.1×78 topics
- Inflammation18▲ 3.1×54 topics
- Chemotherapy15▲ 8.4×22 topics
- Immunotherapy11▲ 6.8×16 topics
- Oxidative Stress10▲ 2.2×33 topics
- Guidelines10▲ 8.1×11 topics
- Treatment9▲ 2.6×31 topics
- Diagnosis9▲ 3.3×28 topics
- Cancer8▲ 2.2×27 topics
- Neoadjuvant Therapy8▲ 14×5 topics
- Quality of Life7▲ 1.99×30 topics
- Molecular Characterization6▲ 14×5 topics
- Prognostic Factors6▲ 5.5×13 topics
- Risk Factors6▲ 2.4×20 topics
- Management6▲ 3.1×18 topics
- Cardiovascular Disease6▲ 2.1×22 topics
- Urothelial Carcinoma5▲ 48×2 topics
- Bladder Cancer5▲ 55×1 topic
- Cystectomy5▲ 55×1 topic
- Global Burden5▲ 3.6×9 topics
- Heart Failure5▲ 4.2×11 topics
- Surgical Management5▲ 4.2×16 topics
- Magnetic Resonance Imaging5▲ 4.9×7 topics
- Graft Survival4▲ 17×3 topics
- Genetic Mutations4▲ 3.3×15 topics
- Clinical Practice Guidelines4▲ 3.0×13 topics
- Mortality4▲ 3.4×9 topics
- Complications4▲ 3.2×12 topics
- Autoantibodies4▲ 6.7×5 topics
- Cardiovascular Risk4▲ 4.3×6 topics
- Immunosuppressive Therapy4▲ 7.8×6 topics
- Mesenchymal Stem Cells4▲ 13×3 topics
- Hematopoietic Stem Cells4▲ 14×3 topics
- Tumor Microenvironment4▲ 4.0×6 topics
- Clinical Outcomes3▲ 6.7×4 topics
- Rituximab3▲ 7.8×3 topics
- Targeted Therapy3▲ 5.5×5 topics
- Transplantation3▲ 10×4 topics
- Liver Transplantation3▲ 7.3×4 topics
- Immunosuppressive Drugs3▲ 16×2 topics
Which research topics does Nebraska Hematology-Oncology publish most on?
By volume in 2022-now: CNS Lymphoma Diagnosis and Treatment, Autoimmune Neurological Disorders and Treatments, Chronic Lymphocytic Leukemia Research and Diabetes Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
- 2 Autoimmune Neurological Disorders and Treatments Neurology 0 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 5 Cancer and Skin Lesions Dermatology 0 works
- 6 Nonmelanoma Skin Cancer Studies Epidemiology 0 works
- 7 Infectious Diseases and Mycology Small Animals 0 works
- 8 Cytomegalovirus and herpesvirus research Epidemiology 0 works
- 9 Aortic Disease and Treatment Approaches Pulmonary and Respiratory Medicine 0 works
- 10 Platelet Disorders and Treatments Hematology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Nebraska Hematology-Oncology's research output changed?
Output in 2022-2025 was 39% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Nebraska Hematology-Oncology as a percentage of every work published that year, 0.0000067% in 2024.
Fractional works of Nebraska Hematology-Oncology over all fractional works that year. How the balance of science has shifted.
Other research institutions in Lincoln
- University of Nebraska–Lincoln
- Entrepreneurial Ecosystems
- University of Nebraska System
- Pacific Engineering (United States)
- Nebraska Wesleyan University
- Nebraska Game and Parks Commission
- Bryan Health
- J.A. Woollam Company (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Nebraska Hematology-Oncology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
